Related Experiment Video
Updated: Mar 29, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Anemia and Mild Cognitive Impairment in the German General Population
Martha Dlugaj1, Angela Winkler1, Christian Weimar1
1Department of Neurology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.
Abstract:
There is increasing evidence that anemia is associated with cognitive impairment. Therefore, the aim of the study was to examine the cross-sectional association of anemia as well as the persistence of anemia over the last five years with mild cognitive impairment (MCI) and MCI subtypes (amnestic/non-amnestic MCI (aMCI/naMCI)). Out of 4,157 participants (50% men, 50-80 years) of the second examination (t1) of a cohort study (baseline (t0) 2000-2003), we included 4,033 participants with available hemoglobin information and complete cognitive assessment. Anemia was defined as hemoglobin <13 g/dl in men (n = 84) and <12 g/dl in women (n = 79). Group comparisons were used to compare the cognitive subtests. To determine the association of MCI with anemia at t1, with anemia five years prior to the cognitive assessment (t0) and anemia at both time points, we used logistic regression models and included 579 participants with MCI and 1,438 cognitively normal participants out of the total cohort. Anemic participants showed lower performances in verbal memory and executive functions. The fully adjusted odds ratios (OR) for MCI, aMCI, and naMCI in anemic versus non-anemic participants were 1.92 (95% -CI, 1.09-3.39), 1.96 (1.00-3.87), and 1.88 (0.91-3.87). Anemia at both times points showed a non-significant association with naMCI (OR 3.74, 0.94-14.81, fully adjusted). Our results suggest that anemia is associated with an increased risk of MCI independent of traditional cardiovascular risk factors. The association of anemia and MCI has important clinical relevance, because many causes of anemia can be treated effectively.
Insights
Anemia is linked to a higher risk of mild cognitive impairment (MCI), affecting memory and executive functions. Treating anemia may help reduce this risk, highlighting its clinical importance.
Area of Science:
- Neurology
- Hematology
- Epidemiology
Background:
- Growing evidence links anemia to cognitive impairment.
- Understanding the relationship between anemia and mild cognitive impairment (MCI) is crucial for public health.
- Anemia's impact on cognitive subtypes requires further investigation.
Purpose of the Study:
- To investigate the association between current anemia and mild cognitive impairment (MCI).
- To examine the link between persistent anemia over five years and MCI.
- To explore the relationship between anemia and specific MCI subtypes: amnestic MCI (aMCI) and non-amnestic MCI (naMCI).
Main Methods:
- Cross-sectional study analyzing data from 4,033 participants (aged 50-80) from a cohort study.
- Anemia defined by hemoglobin levels (<13 g/dl for men, <12 g/dl for women).
- Logistic regression models used to assess the association of anemia at baseline (t0) and follow-up (t1) with MCI, controlling for cardiovascular risk factors.
Main Results:
- Anemic participants demonstrated poorer performance in verbal memory and executive functions.
- Anemia was associated with an increased odds ratio for MCI (1.92), aMCI (1.96), and naMCI (1.88).
- Anemia at both time points showed a non-significant association with naMCI (OR 3.74).
Conclusions:
- Anemia is independently associated with an increased risk of developing MCI.
- The findings underscore the clinical relevance of managing anemia for cognitive health.
- Effective treatments for many anemia causes suggest potential for mitigating cognitive decline.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Development During Adulthood
Psychoneuroimmunology: Diabetes and Cancer
Pharmacodynamics in Geriatric Patients: Effects of Age

